Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5485316 | 0.90 | GRIA2 (0.37) | GRIA2APLNR | |
| SCHEMBL5482325 | 0.89 | GRIA2 (0.51) | GRIA2 | |
| SCHEMBL5479962 | 0.82 | GRIA2 (0.52) | GRIA2 | |
| SCHEMBL5482710 | 0.80 | GRIA2 (0.54) | GRIA2 | |
| SCHEMBL5475951 | 0.79 | GRIA2 (0.68) | GRIA2 | |
| SCHEMBL5482327 | 0.79 | GRIA2 (0.39) | GRIA2APLNR | |
| SCHEMBL5477044 | 0.76 | GRIA2 (0.49) | GRIA2 | |
| SCHEMBL5481538 | 0.76 | GRIA2 (0.72) | GRIA2 | |
| SCHEMBL5481531 | 0.73 | GRIA2 (0.48) | GRIA2 | |
| SCHEMBL5479896 | 0.73 | GRIA2 (0.48) | GRIA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070270415-A1 | Benzothiadiazine compounds | LESLABORATOIRES SERVIER (FR) | 2007-11-22 | — | — | US | disclosed |
| US-20070106083-A1 | Process for preparing 4-aminotetrahydropyran compound and an acid salt thereof, synthetic intermediate thereof and process for preparing the same | UBE INDUSTRIES, LTD. (JP) | 2007-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070270415-A1 | Benzothiadiazine compounds | SLC1A1, SLC1A2, SULT2A1 | GRIA2 47/4885APLNR 4415/4885 |
| US-20070106083-A1 | Process for preparing 4-aminotetrahydropyran compound and an acid salt thereof, synthetic intermediate thereof and process for preparing the same | PAH, HPD, REN | GRIA2 747/4885APLNR 180/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.